As previously reported, BofA upgraded Brown & Brown to Buy from Neutral with a price target of $130, up from $126. Shares have fallen 26% since April 2, which represents “one of the most significant periods of snap underperformance” in the history of the stock, the analyst tells investors. The firm, which notes that its EPS forecasts run ahead of consensus, believes that Brown & Brown’s Q2 results have “reset the outlook to a more steady-state growth rate.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRO:
- Brown & Brown upgraded to Buy from Neutral at BofA
- Brown & Brown Reports Strong Revenue Growth for Q2 2025
- Brown & Brown’s Earnings Call: Growth Amid Challenges
- Baldwin Group has negative read from Brown & Brown report, says BMO Capital
- Hold Rating for Brown & Brown Amidst Slowed Growth and Mixed Deal Impacts
